Join Maine Made Crafts on Saturday and Sunday, August 9 and 10, 2025, from 9 AM to 4 PM for a spectacular showcase of handcrafted delights at the Well ....
Read MoreThe 16th Annual Smuttynose Rockfest Half Marathon and 5K returns to Hampton, NH on Sunday, October 5, 2025. Join thousands of runners as you rock your ....
Read MoreWe are open to the public. All are welcome to attend this Native American Event. There will be Drums, Dancers, Please join us for NH Intertribal Coun ....
Read MoreWelcome to the 6th Annual 2-day Wells Jr High Summerfest Arts and Craft Show! Join Maine Made Crafts and newenglandcraftfairs.com on June 21 and 22, 2 ....
Read MoreMassachusetts Breast Cancer Coalition (MBCC) invites you to join us on the beach for Against the Tide to swim, run, or walk to support breast cancer p ....
Read MoreMassachusetts Breast Cancer Coalition (MBCC) invites you to join us on the beach for Against the Tide to swim, run, or walk to support breast cancer p ....
Read MoreMassachusetts Breast Cancer Coalition (MBCC) invites you to join us on the beach for Against the Tide to swim, run, or walk to support breast cancer p ....
Read MoreMassachusetts Breast Cancer Coalition (MBCC) invites you to join us on the beach for Against the Tide to swim, run, or walk to support breast cancer p ....
Read MoreAs the autoimmune wave breathes financial life back into the allogeneic space, and a growing number of oncology pipelines entering the clinic, it is n ....
Read MoreInfoQ Dev Summit Boston 2025 (June 9-10) is a two-day conference tailored for senior software developers seeking practical solutions to complex challe ....
Read MoreWith Arbor Biotechnologies on-track for year-end IND/CTA filing of their LNP-mediated gene editing therapy and LNPs continuing to be the hottest deliv ....
Read MoreWith nasal delivery systems offering faster absorption and non-invasive administration, they are becoming a cornerstone of modern therapeutics. Whethe ....
Read MoreWith Merck's oral PCSK9 inhibitor demonstrating strong phase 3 trial results, J AND J's IL23R antagonist peptide continuing its phase 3 journey, and C ....
Read More2024 was pivotal for TCR therapies. Following the commercial approval for Adaptimmune's Tecelra, positive clinical readouts, and FIH trials from Immat ....
Read MoreWith the plasmid DNA manufacturing market set to rise to $39.3Bn by 2033, and the demand for advanced therapies continuing to surge as gene therapy re ....
Read MoreAs the biopharma industry evolves with rapid advancements in drug development, manufacturing, and research, EHS leaders are tasked with safeguarding e ....
Read MoreWelcome to the 4th Novel Conjugate Summit! The field of conjugatable drugs is advancing at a rapid pace, with major collaborations like Nurix and Pfi ....
Read MoreWelcome to the 8th Gene Therapy Development Summit Transforming the Future of Gene Therapies for Rare and Common Diseases With 14 new gene therapy a ....
Read MoreOver the past year, the Treg sector has seen groundbreaking investments and strategic collaborations between leading biotech and pharma companies like ....
Read MoreTwo fantastic musicians regale the audience with a range of popular songs, take requests , and "duel" on stage in a fun musical competition.What are d ....
Read MoreExpanded Access Programs (EAPs) are increasingly recognized as an ethical imperative in modern healthcare. More companies are opening EAPs to provide ....
Read MoreIn 2025, the spotlight is on neurodegenerative drug development, driven by the triumph of Lecanemab and Donanemab, coupled with rapid advancements to ....
Read MoreThe transformative era of kidney drug development is here, with 2024 bringing landmark advancements, including Novartis' Borealis Biosciences and appr ....
Read MoreUpdates, advances and practical information you can use now to screen, diagnose and manage patients with kidney diseaseWith more than 50 interactive l ....
Read MoreBoston's #1 St Pats Pub Crawl: The Boston St Patrick's Day Pub Crawl returns March 2025! Secure your spot for the best Boston Pub Crawl! Category: At ....
Read More